Venetoclax (VEN) Plus Intensive Chemotherapy (IC) with FLAG-IDA in Patients (Pts) with Newly Diagnosed (ND) and Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:9036-9038 - Subject
- Language
- ISSN
- 0006-4971